IMMU-07. TACEDINALINE (CI994), A CLASS I HDAC INHIBITOR, TARGETS INTRINSIC TUMOR GROWTH AND LEPTOMENINGEAL DISSEMINATION IN MYC-DRIVEN MEDULLOBLASTOMA WHILE MAKING THEM SUSCEPTIBLE TO ANTI-CD47 INDUCED MACROPHAGE PHAGOCYTOSIS VIA NF-KB-TGM2 DRIVEN TUMOR INFLAMMATION
Authors: Viktoria Marquardt, Johanna Theruvath, Nan Qin, Daniel Picard, Rajeev Vibhakar, Sujatha Venkararaman, Marc Remke, Siddhartha Mitra
Published: 2023-06-12
DOI:
10.1093/neuonc/noad073.194
Source:
Full article
Abstract
Abstract